Propanc Biopharma, Inc.

302, 6 Butler Street

Camberwell, VIC, 3124 Australia


February 11, 2020




U.S. Securities & Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549


  Re: Propanc Biopharma, Inc
    Registration Statement on Form S-1/A
    File No. 333-235479


Ladies and Gentlemen:


In accordance with Rule 461 of the Securities Act of 1933, as amended, Propanc Biopharma, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-captioned Registration Statement (the “Filing”) be accelerated so that it will be declared effective at 10:00 a.m. Eastern Time on Friday, February 14, 2020, or as soon thereafter as possible.


* * * *


Very Truly Yours,


Propanc Biopharma, Inc.  
/s/ James Nathanielsz.  
James Nathanielsz  
Chief Executive Officer